Upgrade to SI Premium - Free Trial

Bernstein SocGen Group Reiterates Outperform Rating on Celestica (CLS)

October 15, 2026 8:27 AM
Bernstein SocGen Group analyst Daniel Zhu reiterated an Outperform rating and $520.00 price target on Celestica (NYSE: CLS).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments